Home > Insider Trading > Filing (0001181431-13-064642)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1017491	Apricus Biosciences Inc.	APRI	Pharmaceutical Preparations (2834)	870449967

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1283304	G Kleanthis Xanthopoulos	11975 El Camino Real, Suite 300 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-26	17,184	$2.55	55,735	No	4	S	Indirect	By Kleanthis & Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Kleanthis & Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.